SREBP
Inhibitory Selectivity
SREBP Products
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S8284 |
Fatostatin HBrFatostatin is an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2. |
||
| S9785New |
FatostatinFatostatin (125B11), a diarylthiazole derivative, is a specific inhibitor of Sterol regulatory element binding proteins (SREBPs) activation. Fatostatin binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin suppresses growth and enhances apoptosis in cancer cells. |
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S8284 |
Fatostatin HBrFatostatin is an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2. |
||
| S9785New |
FatostatinFatostatin (125B11), a diarylthiazole derivative, is a specific inhibitor of Sterol regulatory element binding proteins (SREBPs) activation. Fatostatin binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin suppresses growth and enhances apoptosis in cancer cells. |
